On Jul 20, 2021 Eyenuk, Inc. received $6,200,000 financing from AXA Investment Managers and Global Health Investment Fund (GHIF). The company plans to close a […]
Series B – Castor
On Jul 14, 2021, Castor closed a Series B round and raised $45,000,000 from Eight Roads Ventures, F-Prime Capital, INKEF Capital, Two Sigma Ventures, Eight […]
Post-IPO Equity – Adial Pharmaceuticals
On Jul 7, 2021 Adial Pharmaceuticals closed a private placement of 700,001 shares of common stock and raised $5,000,000 from Bespoke Growth Partners, Keystone Capital […]
Series C – Standigm
On Jul 6, 2021, Standigm closed a Series C round and raised $10,000,000 from lead investor Pavilion Capital. About the company: Standigm is located in […]
Series C – TCR Cure
On Jul 1, 2021 TCR Cure closed a Series C round and raised $50,000,000. About the company: TCR Cure is located at China, Asia. “TCRCure […]
Secondary Market – PharmEasy
On Jun 17, 2021 PharmEasy closed a Secondary Market round and raised $20,000,000 featuring lead investor B Capital Group. About the company: PharmEasy is located […]
